Higher Trump tariffs soon? US Treasury Secretary Bessent says rates could be restored by July

Soon after the US Supreme Court verdict, Trump announced a 10% universal tariff. (AI image) Will Donald Trump administration’s high reciprocal tariffs come back to haunt global economies? Treasury Secretary Scott Bessent on Tuesday indicated that Trump’s tariff measures could be reinstated by July, potentially returning to the levels that existed before the Supreme Court…

Read More

Stock market today (April 15, 2026): Nifty50 opens above 24,200; BSE Sensex rallies over 1,200 points as oil prices drop on US-Iran peace talks optimism

Stock market today (AI image) Stock market today: Sensex and Nifty50 rallied strongly in opening trade on Wednesday after optimism surrounding renewed US-Iran peace talks led oil prices to drop. While Nifty50 went above 24,200, BSE Sensex rose over 1,200 points. At 9:17 AM, Nifty50 was at around 24,223.45, up 381 points or 1.60%. BSE…

Read More

Drone-based land mapping boosts rural credit flows

MUMBAI: Govt’s shift to drone-based land mapping has lifted rural credit flows, with sanctioned loan amounts rising 23% after residential plots were converted into verifiable collateral under the SVAMITVA scheme, according to an April 2026 working paper published by the economic advisory council to the Prime Minister.The move replaces informal land demarcation with legally recognised,…

Read More

Infosys rolls out ‘silicon to application’ AI strategy

Bengaluru: Infosys has set its new AI strategy, “silicon to application,” in motion. The playbook aims to span the full AI ecosystem-from hardware to end-user applications-through targeted investments and partnerships across each layer.At the silicon layer, Infosys has partnered with Nvidia and Intel. “These partnerships matter most when clients need AI to run on their…

Read More

`Indian pharma must balance generics with innovation’

NEW DELHI: India’s pharmaceutical industry must focus on both generics and innovative products, as well as develop products specially tailored for the country’s patient needs. Domestic companies particularly smaller to mid-sized players can carve out a strong role in rare diseases and niche patient segments, where agility and specialised research can drive meaningful breakthroughs, pharma…

Read More